ID   LG2-MEL-5-35isc3.1.1
AC   CVCL_C5UU
DR   Wikidata; Q116049699
RX   PubMed=12747754;
CC   Characteristics: Obtained by in vitro immunoselection of the parent cell line with the anti-LG2-B CTL clones (PubMed=12747754).
CC   Sequence variation: Mutation; HGNC; HGNC:16994; OS9; Simple; p.Pro446Leu (c.1337C>T); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5UR ! LG2-MEL-5-35
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
RX   PubMed=12747754;
RA   Vigneron N., Ooms A., Morel S., Degiovanni G., van den Eynde B.J.;
RT   "Identification of a new peptide recognized by autologous cytolytic T
RT   lymphocytes on a human melanoma.";
RL   Cancer Immun. 2:9-9(2002).
//